Arvinas (ARVN) Share-based Compensation (2017 - 2026)

Arvinas (ARVN) recorded quarterly Share-based Compensation of $12.1 million in Q1 2026, up 42.35% quarter-over-quarter from $8.5 million in Q4 2025, and down 19.33% on a YoY basis from $15.0 million in Q1 2025.

Arvinas (ARVN) Share-based Compensation (2017 - 2026) Analysis & Trends

Arvinas' Share-based Compensation history runs 10 years deep, the most recent figure standing at $12.1 million for Q1 2026.

  • In Q1 2026, Share-based Compensation fell 19.33% year-over-year to $12.1 million; the TTM figure through Mar 2026 stood at $41.1 million (down 51.42% YoY), while the FY2025 annual figure was $44.0 million, down 50.11% from the prior year.
  • Share-based Compensation was $12.1 million for Q1 2026 at Arvinas, up from $8.5 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $24.7 million in Q3 2024 to a low of $8.5 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $17.1 million across 5 years, with a median of $18.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation jumped 61.17% in 2022, then sank 63.52% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $20.1 million in 2022, then fell by 16.92% to $16.7 million in 2023, then surged by 39.52% to $23.3 million in 2024, then tumbled by 63.52% to $8.5 million in 2025, then soared by 42.35% to $12.1 million in 2026.
  • The last three Share-based Compensation figures came in at $12.1 million (Q1 2026), $8.5 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 12.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.10 Mn
Mar 31, 2026 12.10 Mn
Dec 31, 2025 8.50 Mn
Dec 31, 2025 8.50 Mn
Sep 30, 2025 10.20 Mn
Sep 30, 2025 10.20 Mn
Jun 30, 2025 10.30 Mn
Jun 30, 2025 10.30 Mn
Mar 31, 2025 15.00 Mn
Mar 31, 2025 15.00 Mn
Dec 31, 2024 23.30 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 24.70 Mn
Sep 30, 2024 24.70 Mn
Jun 30, 2024 21.60 Mn
Jun 30, 2024 21.60 Mn
Mar 31, 2024 18.60 Mn
Mar 31, 2024 18.60 Mn
Dec 31, 2023 16.70 Mn
Dec 31, 2023 16.70 Mn